Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2003
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347955A1 New mandelic acid derivatives and their use as throbin inhibitors
10/01/2003EP1347780A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
10/01/2003EP1347778A1 Behavior chemotherapy
10/01/2003EP1347773A2 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
10/01/2003EP1347762A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
10/01/2003EP1347761A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/01/2003EP1347760A2 Nmda receptor agonist pharmaceutical compositions
10/01/2003EP1347756A2 Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003EP1347748A2 Hydrostatic delivery system for controlled delivery of agent
10/01/2003EP1347746A1 Over-coated chewing gum formulations including tableted center
10/01/2003EP1347745A2 Dietary composition containing conjugated linoleic acid and calcium for improved health
10/01/2003EP1237854B1 Comminuted form of (s)-2-ethoxy -3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid
10/01/2003EP1206472B1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
10/01/2003EP1204655B1 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
10/01/2003EP1202954B1 Novel aminobenzophenones
10/01/2003EP1200447B1 Oxazinocarbazoles for the treatment of cns diseases
10/01/2003EP1200435B1 Purine derivatives inhibitors of tyrosine protein kinase syk
10/01/2003EP1094843B1 Targeted site specific drug delivery compositions and uses
10/01/2003EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
10/01/2003EP0999854B1 Switchable viscoelastic systems containing galactomannan polymers and borate
10/01/2003EP0998473B1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
10/01/2003EP0996621B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
10/01/2003EP0811008B1 Bicyclic benzazepine derivatives as vasopressin antagonists
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446217A Beta-carboline derivatives useful as inhibitors of phosphodiesterase
10/01/2003CN1446214A Cinnoline compounds
10/01/2003CN1446212A Quinoline derivatives having VEGF inhibiting activity
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446199A New amidino derivatives and their use as thrombin inhibitors
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/01/2003CN1446193A Aminoadamantane derivatives as therapeutic agents
10/01/2003CN1446128A Compositions inchuding ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
10/01/2003CN1446108A Pharmaceutical form comprising a support material and at least a cell regulating factor and/or cell proliferation promoter
10/01/2003CN1446105A Medicinal compositions for angiogenic therapy
10/01/2003CN1446101A Combination product comprising melagatran and factor VLLa inhibitor
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1446084A Treatment of insulin resistance syndrome
10/01/2003CN1445366A New protein kinase specific to human cardiac muscle and its coded sequence
10/01/2003CN1445228A Application of active ingredient of coumarin category distilled from dahurian angelica in preparing medicine for curing high blood pressure and its extracting method
10/01/2003CN1445226A New cornpound derivated from quinazoline, itd preparation method and medicinal composite containig them
10/01/2003CN1445225A Intermediate for preparing benzothiophene amide derivate
10/01/2003CN1445218A 3-phenyl pyrazole-5-ramification of carboxylic acid derivative as well as its preparing method and medicine appliction
10/01/2003CN1444986A Preparation of Chinese herbal medicine for treating sequela of apoplexy and its preparing method
10/01/2003CN1444981A Medicine for treating cardiovascular diseases and its preparing method
10/01/2003CN1444977A Medicine combination containing valid part of ÔÇÿRuyi Jinhuang SanÔÇÖ and its preparing method
10/01/2003CN1444971A Preparation of Chinese herbal medicine for lowering the blood pressure
10/01/2003CN1444965A Medicine for treating heart disease
10/01/2003CN1444963A Medicine for treating thrombus disease
10/01/2003CN1444949A Astragalus root valid part of Chinese herbal medicine for treating cardiovascular disease
10/01/2003CN1444948A Liposome of Breviscapine and its preparing method
10/01/2003CN1444947A Breviscapine drop pills and its preparing method
10/01/2003CN1444944A Cyclovirobuxinum D. drop pills and its preparing method
10/01/2003CN1444943A Pentoxifylline tablet controlled relasease tablet
10/01/2003CN1444934A Method for eliminating strange smell of oral medicine of L-arginine
10/01/2003CN1444931A Aceglutamide injection
10/01/2003CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same
10/01/2003CN1122667C Process for preparing N6-substituted deaza adenosine derivatives
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
10/01/2003CN1122528C Compound safflower oil preparation and medicine containing it
10/01/2003CN1122519C Chinese-medicine for treating hypertension and its preparing process
09/2003
09/30/2003US6627769 Antiproliferative agents
09/30/2003US6627662 3-amino-propoxyphenyl derivatives (I)
09/30/2003US6627658 Administration of an effective amount of 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4, Lipoxin-A4, 15-epi-lipoxin4 or 15-R/S-methyl-lipoxin4 or salts, esters, amides, carboxylic acids or prodrugs to treat angiogenesis
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627652 Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
09/30/2003US6627649 (2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4 -dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2 -carbonyl)pyrrolidine-2-carboxamide, a selective V1a arginine vasopressin receptor antagonist, in combination with the
09/30/2003US6627643 Sodium-hydrogen exchanger type 1 (NHE-1) inhibitors of formula I' are useful for the prevention and treatment of myocardial ischemic injury. Myocardial ischemic injury can occur in out-patient in perioperative settings and can lead to sudden
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627628 Cardiovascular diseases such as hypertension, angina pectoris, heart failure, thrombosis and atherosclerosis. The compounds of formula (I) are able to modulate the body's own production of cyclic guanosine monophosphate (cGMP) and are suitable for
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627604 Memno peptides, process for their preparation and use thereof
09/30/2003US6627602 Preventing desensitization of receptors
09/30/2003US6627439 Cancer diagnosis, therapy; Dna vaccine
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627231 Protecting cell from damage caused by free radicals by administering lipophilic antioxidant comprising vitamin E, beta carotene, extract of Lycopersicum esculentum, hydrophilic antioxidant comprising vitamin c, extract of vitis vinifera
09/30/2003US6626982 Compound storage
09/30/2003US6626932 Therapeutic light source and method
09/30/2003CA2279796C Process for the preparation of substituted pyridines
09/30/2003CA2254750C Inhibition of matrix metalloproteases by 2-(.omega.-aroylalkyl)-4-biaryl-oxobutyric acids
09/30/2003CA2108788C Liposomal prostaglandin formulations
09/30/2003CA2099585C Pharmaceutical compositions
09/29/2003CA2423248A1 Polymorphic forms of fasidotril, procedures for their preparation and pharmaceutical compounds that contain them
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078568A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
09/25/2003WO2003078465A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
09/25/2003WO2003078441A1 Aminomethyl-substituted thiazolobenzimidazole derivative
09/25/2003WO2003078435A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
09/25/2003WO2003078434A1 Ethane-1,2-diamino-bis[(2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
09/25/2003WO2003078431A1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
09/25/2003WO2003078428A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/25/2003WO2003078427A1 Azolylaminoazines as inhibitors of protein kinases
09/25/2003WO2003078426A1 Azolylaminoazine as inhibitors of protein kinases
09/25/2003WO2003078425A1 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
09/25/2003WO2003078422A1 Novel pyridone derivative
09/25/2003WO2003078421A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078419A1 N-substituted benzothiophenesulfonamide derivative
1 ... 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 ... 1595